Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes

Contemporary Clinical Trials

Volumn 34, Issue 2, 2013, Pages 212-217

  Arikawa, Andrea Y ^a   Thomas, William ^b   Gross, Myron ^c   Smith, Alma ^a   Phipps, William R ^c   Kurzer, Mindy S ^a   Schmitz, Kathryn H ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Body composition; Exercise; F2 isoprostanes; Fitness; Women

Indexed keywords

ISOPROSTANE DERIVATIVE;

ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; ARTICLE; BODY FAT; CONTROLLED STUDY; FEMALE; FITNESS; HUMAN; HUMAN EXPERIMENT; MASS FRAGMENTOGRAPHY; NORMAL HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; EXERCISE; EXERCISE THERAPY; F2-ISOPROSTANES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; OXIDATIVE STRESS; PHYSICAL FITNESS; REACTIVE OXYGEN SPECIES; SEDENTARY LIFESTYLE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871661481     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.11.003     Document Type: Article

References (27)

1. 2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008, 10:1405-1434.
2. Vincent H.K., Innes K.E., Vincent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007, 9:813-839.
3. Klaunig J.E., Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004, 44:239-267.
4. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 1992, 89:10721-10725.
5. 2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:639-644.
6. Dai Q., Gao Y.T., Shu X.O., Yang G., Milne G., Cai Q., et al. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study. J Clin Oncol 2009, 27:2482-2488.
7. Brys M., Morel A., Forma E., Krzeslak A., Wilkosz J., Rozanski W., et al. Relationship of urinary isoprostanes to prostate cancer occurrence. Mol Cell Biochem 2012, 372:149-153.
8. 2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 2008, 29:971-976.
9. Arikawa A.Y., O'Dougherty M., Kaufman B., Smith A., Thomas W., Warren M., et al. Women in Steady Exercise Research (WISER): study design and methods. Contemp Clin Trials 2010, 31:457-465.
10. 2-isoprostanes in biological fluids and tissues as measure of oxidant mechanism. Methods Enzymol 1999, 300:3-12.
11. Begg C.B. Suspended judgment. Significance tests of covariate imbalance in clinical trials. Control Clin Trials 1990, 11:223-225.
12. Altman D.G., Dore C.J. Baseline comparisons in randomized clinical trials. Stat Med 1991, 10:797-799.
13. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
14. D'Agostino R. Tutorial in biostatistics: propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17:2265-2281.
15. Coca-Perraillon M. Local and global optimal propensity score matching. SAS Global Forum 2007.
16. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.
17. Schmitz K.H., Warren M., Rundle A.G., Williams N.I., Gross M.D., Kurzer M.S. Exercise effect on oxidative stress is independent of change in estrogen metabolism. Cancer Epidemiol Biomarkers Prev 2008, 17:220-223.
18. Arikawa A.Y., O'Dougherty M., Kaufman B.C., Schmitz K.H., Kurzer M.S. Attrition and adherence of young women to aerobic exercise: lessons from the WISER study. Contemp Clin Trials 2012, 33:298-301.
19. Kushi L.H., Byers T., Doyle C., Bandera E.V., McCullough M., McTiernan A., et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006, 56:254-281. [quiz 313-4].
20. Roberts C., Vaziri N., Barnard R. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002, 106:2530-2532.
21. Devries M.C., Hamadeh M.J., Glover A.W., Raha S., Samjoo I.A., Tarnopolsky M.A. Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women. Free Radic Biol Med 2008, 45:503-511.
22. Galassetti P.R., Nemet D., Pescatello A., Rose-Gottron C., Larson J., Cooper D.M. Exercise, caloric restriction, and systemic oxidative stress. J Investig Med 2006, 54:67-75.
23. 2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 1999, 48:1402-1408.
24. Campbell P.T., Gross M.D., Potter J.D., Schmitz K.H., Duggan C., Anne A., et al. Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 2010, 42:1448-1453.
25. Kadiiska M.B., Gladen B.C., Baird D.D., Germolec D., Graham L.B., Parker C.E., et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med 2005, 38:698-710.
26. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995, 332:1198-1203.
27. Friedenreich C.M., Neilson H.K., Lynch B.M. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010, 46:2593-2604.